Q2-FY27 Earnings Intelligence
EXPLEOSOL
NSE↗BSE↗Small Cap🔵Founder / Family
Expleo Solutions
Information Technology›IT - Services›IT Enabled Services
Current Price₹772.7(+1.01%)
Market Cap₹1,199 Cr
Analysis WindowQ2 FY27
Last Updated19 Nov 2026
Flagium AI Risk Score
Risk Score measures the severity of detected structural financial risks using Flagium's quantitative risk framework. A lower score indicates fewer or less severe detected risks (0 = Minimal Risk, 100 = Severe Risk). Quarter-to-quarter changes reflect changes in the underlying risk signals, not investment recommendations.
34/ 100
Scale: 0 = Clean • 100 = Severe Risk (Lower is safer)79th Percentile · Sector
Risk ClassWatch
Risk Trend
Early DeteriorationQoQ Delta +18 pts
Business🟡 Watch
Primary DriverGovernance Integrity Shock
Valuations✓ Conservative
Expectation Gap+99.7%Valuation Risk: Low
Market Structure○ Topping
Stage 34 sessions

Improving fundamentals and stabilizing technical baseline. Base building process active. Valuations remain conservative and supported by current metrics.

Market Alignment🟡Partial ConfirmationMarket structure shows partial alignment with the underlying fundamental risk profile.

SENTINEL REVIEW

Expleo Solutions (EXPLEOSOL)•Updated yesterday

EXECUTIVE FORENSIC DIAGNOSIS
15 Nov 2026

🚨 Structural Deterioration Signature: In Q2 FY2027, Expleo Solutions reported a 2.4% YoY revenue growth to ₹302.6 Cr, but net profit contracted by 8.5% to ₹36.4 Cr, with EBITDA margins compressing by 3.4 pp to 16.7%. This deterioration persists across interim quarters since FY2026, with Q1 FY2027 showing 12.0% revenue growth and Q2 FY2027 confirming a 2.4% YoY revenue expansion, though net profit remained under sector median performance. The operational strain is compounded by elevated governance risks, with two board-level resignations in Q2 FY2027, and a cash conversion deficit, though operating cash flow (₹119.5 Cr) has normalized. The company’s zero-debt profile and working capital (trade receivables: ₹229.6 Cr) provide liquidity capacity, but relative growth weakness and governance integrity shocks push the firm into Flagium’s heightened surveillance range.

WHAT CHANGED THIS QUARTER
  • ✗Risk score deteriorated (QoQ change: +18 pts)
  • ✓Profitability margins pressure eased
  • ✗New risk trigger: Relative Growth Weakness (+10.6 pts)
  • ✓Growth expectations are conservative
  • ✓Market structure is neutral/stabilizing
  • ✗A/D flow regime is Neutral (-0.11σ)
  • ✗Share price is down -9.9% this quarter (from ₹857.85 on 30 Sept to ₹772.7)
DUE DILIGENCE CHECKLIST
  • 🔴Review 2 active forensic warning flags for structural stress
  • 🟠Track earnings quality and working capital trends in next filing
  • 🟢Maintain routine quarterly surveillance; no governance escalation required
RISK CONTRIBUTORS
  • 20.1 ptsGovernance
  • 13.9 ptsCompetitive Position
NEED CLARIFICATION ON THIS QUARTER'S AUDIT?

Divergence Radar

BUSINESS STRENGTH66/100
VALUATION ATTRACTIVENESS (MARGIN OF SAFETY)52/100
MARKET TREND STRUCTURE40/100
A/D FLOW ACCUMULATION47/100

Structural Matrix

Valuation
Business Quality
Attractive
Balanced
Demanding
Strong
Moderate
Weak
🟢
Profile: MODERATE × ATTRACTIVE VALUATION

Risk vs Price Timeline
Visualizing the historical relationship between the structural risk score and stock price movement over time.

Loading Chart
Share Price
Risk Score (0-100)
Market Performance
₹772.7(+1.01%)
1M Divergence-8.33%
DurationPerf.Sector AvgDivergence
1 Week-8.94%-3.1%-5.84%
1 Month-11.75%-3.42%-8.33%
6 Months-14.32%+1.24%-15.56%
1 Year-29.23%-12.55%-16.69%
2 Year-38.38%-0.87%-37.51%
3 Year-36.76%+59.66%-96.43%

Business Analysis Methodology

Business analysis focuses on structural risk inside the company. Flagium monitors earnings quality, balance sheet strength, liquidity, governance, competitive position, and growth sustainability to identify areas where risk may be increasing or decreasing before it becomes obvious in reported results.

Flagium AI Risk Score34 / 100Riskier than 79% of Sector Peers
Risk Class
Watch
Risk Trend+18 QoQ · Early DeteriorationRisk score deteriorated (+18 pts)
Stress MomentumRising (2 Qtrs)Deteriorating for 2 qtrs
Severe Risk Chance5%
Low / Manageable
Interpretation

Financial profile remains stable for now. Weakness is detected in governance. This suggests a building risk profile. Risk is increasing at a faster pace.

Risk Score Composition

Absolute point contribution of each forensic risk driver to the final composite risk score.
Governance
+20.1 pts
Competitive Position
+13.9 pts
Final Composite Risk34 / 100

Investment Risk Thesis

Historical Trend

Current risk score has risen from 9 → 34 over 12 quarters.

Expected Direction
ESCALATING RISK
Primary Deterioration Drivers
NEWRelative Growth Weakness
+10.6 pts
ESCGovernance Integrity Shock
+3.2 pts
What to Watch Next Quarter
  • Operating profit margins

Risk Drivers (Active Warnings)

Governance Signals
■Governance Integrity Shock
SEVEREAccelerating
Competitive Position
■Relative Growth Weakness
MEDIUMPersistent
Decaying / Resolved Signals (12Q Surveillance)
✓ Cash Conversion Deficit (FY2026)

Primary Driver & Insights

Key Contributor
Governance Signals
■Governance Integrity ShockSEVERE
Forensic Analyst Insight

Governance Integrity Shock is currently the primary contributor to forensic pressure. Ongoing monitoring of cash generation and balance sheet quality is warranted in upcoming quarters.

Advanced Business Analytics

Active Risk Objects (3)Free Preview (2 of 3)

CriticalHigh
[G2]Governance Integrity Shock
Governance SignalsQuarterlyActive for 2 Qtrs
GovernanceHigh Tier
Accelerating Risk
Signal MomentumAccelerating
Historical BaselineClean Governance: 0 Material Resignations
Empirical Trigger

EXPLEOSOL: Key governance event detected: DIRECTOR_RESIGNATION.

Forensic Implication

Governance risk is elevated. Monitor board actions and promoter alignment.

Statutory XBRLFiling Period: Q2 FY2027
[I3]Relative Growth Weakness
Earnings QualityQuarterlyActive for 4 Qtrs
Rev GrowthHigh Tier
2.4%Sec 16.1%
Signal MomentumPersistent
Historical BaselineSec Median: 16.1%
Empirical Trigger

Revenue growth consistently lags behind sector median (16.1%).

Forensic Implication

Early signs of earnings quality decay. Profitability is being driven by non-core items.

Statutory XBRLFiling Period: Q2 FY2027
🔒
⭐ Pro Forensic Intelligence

Unlock All 3 Forensic Signals (1 Additional Warnings Gated)

Free accounts preview the top 2 highest-impact warning signals. Upgrade to Flagium Pro to inspect all 3 active forensic detectors, multi-quarter duration streaks, and financial stress metrics for Expleo Solutions.

Unlock with Pro Free →🎁 3-Month Free Trial Available

Statutory Note: Forensic signals are algorithmic quantitative observations derived from publicly filed XBRL disclosures and do not constitute allegations of legal misconduct or investment recommendations.

Unlock Interactive Signal Evidence Dossier

Access complete multi-quarter financial evidence, 5-KPI snapshot strips, diagnostic hypotheses, and 1-page forensic PDF dossiers for Expleo Solutions.

Risk Trajectory
Historical 12-quarter risk trend (Q-11 to Q0) followed by a 2-quarter predictive funnel (Q+1, Q+2).
Loading Chart
Business Stability
Key indicators of structural risk, cash buffer capability, and risk progression.
Shock ResistanceHigh
Severe Risk ChanceLow
Financial StabilityHigh
Margin of SafetyHigh
Forensic Benchmark Context: Information Technology (n=109 peers)

Structural Risk Attribution

Auditable forensic risk attribution explaining why the Flagium AI Risk Score changed between quarters. Deconstructs the score delta into new triggers, severity escalations, cross-pillar contagion overlays, and rules no longer triggered in the latest quarter.

Deterministic quarter-on-quarter causal decomposition grounded in statutory exchange filings.

Peer Benchmark:Information Technology(n=109 peers)
Median Risk: 16/100Position: 79th Percentile

Historical Trajectory (12Q)

← Swipe older12Q window
0/100
Base
0/100
0/100
0/100
0/100
0/100
5/100
10/100
13/100
8/100
16/100
34/100
BREAKLATEST
16➔34/100
▲18-point deterioration(Q1 FY27 ➔ Q2 FY27)
Structural Break Quarter
Auditable forensic risk attribution explaining why the Flagium AI Risk Score changed between quarters.
Executive Synthesis:

Risk deteriorated materially (+18.0 pts), driven by new Relative Growth Weakness (+10.6 pts) and Governance Integrity Shock (+3.2 pts).

Reconciliation Bridge· Swipe ➔
Deterministic Statutory Flow
Base16Q1 FY27
➔
+ New Stress+13.82 flags
➔
- Resolved00 flags cleared
➔
Scaling & Drift
Net calibration combining economic pillar capacity ceiling (+4.2 pts) and temporal volatility dampening (0 pts).
+4.2Pillar Cap & Drift
➔
Terminal34+18 net · Q2 FY27
What Changed This Quarter2 Active Catalysts
New Stress (1 Flag)
+10.6 pts
Competitive Position·MEDIUM Risk
• Trigger:Revenue growth consistently lags behind sector medians.
Revenue YoY:+2.4%PAT YoY:-8.5%
Escalated Stress (1 Flag)
+3.2 pts
Governance·Escalated Risk
• Trigger:Audit quality or leadership instability.
Revenue YoY:+2.4%PAT YoY:-8.5%
Risk Pillar Changes
Net shift in risk score points contributed by each fundamental economic pillar between the two quarters.
6 Fundamental Pillars
Balance Sheet Stress—
Q1 FY27: 0→Q2 FY27: 0
Competitive Position+14.1 pts
Q1 FY27: 0→Q2 FY27: 14.1
Earnings Quality—
Q1 FY27: 0→Q2 FY27: 0
Governance+4 pts
Q1 FY27: 16.2→Q2 FY27: 20.2
Growth Sustainability—
Q1 FY27: 0→Q2 FY27: 0
Solvency—
Q1 FY27: 0→Q2 FY27: 0

12Q Structural Regimes & Inflections

Deterministic macro trajectory milestones
STRUCTURAL BREAK — Q2 FY2716 → 34 | +18 pts

Risk deteriorated materially (+18.0 pts), driven by new Relative Growth Weakness (+10.6 pts) and Governance Integrity Shock (+3.2 pts).

Forensic Trajectory Shifts:
•New Forensic Triggers: 1 new risk signal emerged: Relative Growth Weakness
•Governance Integrity Shock Escalation: Contribution increased by +3.2 pts (severity unchanged at SEVERE)
•Finding: Revenue growth consistently lags behind secto...
•Revenue YoY: +2.4%

Business Resilience & Benchmark Context

Overall: HEALTHY
Solvency(10)Excellent★★★★★
█████100th %ile
Governance(2)Weak★☆☆☆☆
█░░░░20th %ile
Earnings Quality(10)Excellent★★★★★
█████100th %ile
Balance Sheet Stress(10)Excellent★★★★★
█████100th %ile
Competitive Position(3)Weak★★☆☆☆
██░░░30th %ile
Growth Sustainability(10)Excellent★★★★★
█████100th %ile

PEER COMPARISON MATRIX

Ranked surveillance & credit risk comparison against sector peers

Company displays higher risk profile compared to the Sector Mean (16).

* Peer comparison is based on risk signals, not valuation or returns.

Unlock 5-Year Forensic Divergence Cockpit

Access multi-year visual divergence charts (EBITDA vs CFO Cash Gap, Receivables Decoupling Spread, and Debt vs FCF Burn) for Expleo Solutions.

FINANCIAL STATEMENTS

Financial SummaryAudited · Consolidated
Operating Margin (OPM)
16.9%
Weakening↓
Cash Conversion (CCC)
55 Days
Weakening↓
Debt / Equity Ratio
Zero Debt
Stable↔
Revenue Trend
₹1,146 Cr
Growing↑
Swipe for all periods ⇆
MetricFY2026FY2025FY2024FY2023FY20223Y CAGR
Structural triggers––––
Revenue1,1461,041972919408+8%
growth % YoY+10.1%+7.1%+5.8%+125.3%——
EBITDA19318215621681-4%
margin %16.9%17.5%16.0%23.5%19.8%—
Net Profit1241039013454-3%
margin %10.8%9.9%9.3%14.6%13.2%—
CFO119179712338+73%
CFO / Net Profit0.96x1.74x0.79x0.17x0.70x—
Debt———0.47——
Structural triggers first appear in FY2026 (ringed).

Working Capital & Forensic Monitor

Operating Cycle Disclosures·10 Fiscal Years

Cash Conversion Cycle
55 days-2d YoY
Receivables:-5d
Inventory:0d
Payables:-3d
Net Working Capital
₹172 Cr
5-Year Average Cycle: 66 days
Earnings-to-Cash Divergence
₹5 Cr
PAT − CFO (Working Capital Drag)
5Y Cum: ₹75 Cr
Accrual Quality Monitor
Clean (Cash Backed)
Accruals: 0.51% of Avg Assets

Working Capital Schedule (INR Cr)

Metric / RatioFY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Trade Receivables(₹ Cr)
230222249239——————
Inventories(₹ Cr)
0000——————
Trade Payables(₹ Cr)
57612864——————
Net Working Capital(₹ Cr)
172161222176——————
Working Capital / Sales(%)
15.0%15.5%22.8%19.1%——————

Cash Conversion & Operating Cycle (Days)

Metric / RatioFY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash Conversion Cycle (CCC)(days)
55d57d84d70d——————
Debtor Days (DSO)(days)
73d78d94d95d——————
Inventory Days (DIO)(days)
0d0d0d0d——————
Creditor Days (DPO)(days)
18d21d10d25d——————

Forensic Accounting Monitor & Divergences

Metric / RatioFY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Receivable Growth vs Sales (Δ)(%)
-6.8%-17.9%-1.6%———————
Inventory Growth vs Sales (Δ)(%)
——————————
Asset Growth vs Sales (Δ)(%)
+1.7%+1.6%-1.0%—————+7.5%—
Earnings-to-Cash Divergence (PAT - CFO)(₹ Cr)
5-761911116———7-18
Accrual Ratio (Accruals / Avg Assets)(%)
0.5%-9.6%2.5%15.2%————3.9%-10.5%
Operating Cash Realisation (CFO / EBITDA)(%)
67.4%128.9%59.7%12.4%52.4%———62.5%102.4%
Capitalisation Intensity (CWIP / Assets)(%)
——————————
Shareholding Pattern & Pledging Monitor12QZero Pledge🔵Founder / Family
Ownership structure stable
Promoter holding 71.05% unchanged across 12 quarters · zero pledge or encumbrance · institutional holding 0.55%
Q2 FY2027 · latest disclosed quarter
Net Capital Flow (Q2 FY2027):FII +0.03 ppDII +0.27 ppPromoters 0 ppPublic -0.3 pp
FII+DII Net: +0.3 pp
Latest Ownership Distribution (Q2 FY2027)100.00%
Promoters (71.05%)
FII (0.16%)
DII (0.39%)
Public (28.40%)
Quarterly Progression
4 unchanged — Promoters 71.05% · Government 0.00% · Promoter Pledge (% Prom) 0.00% · Total Pledged (% Eq) 0.00% across 12 quarters

* Sourced from quarterly shareholding pattern disclosures filed under Regulation 31 of SEBI (LODR) Regulations. Pledged shares include encumbrances, non-disposal undertakings (NDU), and liens.

🎙️

Concall & Management Takeaways

Q2-FY27
Investor Earnings Call Transcripts & Tone Analysis

Q2-FY27 Results Published • Concall Ingestion Active

Flagium AI is monitoring regulatory exchange filings (NSE/BSE) for EXPLEOSOL's official conference call transcript. Executive themes and management tone will automatically appear once filed.

View Q2-FY27 Results →
Sentinel Forensic AssessmentALGORITHMIC RISK PROFILE • NON-ADVISORY
Fundamental Status

Business quality remains stable.

Forensic Pressure

Current forensic pressure is elevated and stable.

Primary Risk Vectors

Key risks remain concentrated in growth sustainability and operating leverage.

The risk profile is Watch and currently deteriorating. Recent structural triggers in governance suggest a building pressure on the underlying framework. Material forensic traces are visible in structural transparency and audit trails, indicating a progressive erosion of structural stability. Strategic vigilance is advised as structural decay is accelerating.

Market Expectation Engine

CONSERVATIVE EXPECTATIONS

Investor Translation • What the market price is expecting

Expectation Engine

At the current price of ₹773, the market expects this company to grow its net profits by -4.8% every year for the next 5 years. If you think the company will grow faster than -4.8%, current market prices reflect a discount relative to that growth assumption.

Sentinel Takeaway:The market currently expects future growth below the company's historical delivery record. Expectations appear conservative relative to the business's track record, resulting in lower expectation risk.

Market-Implied Growth-4.8%Future Growth Needed
Historical Delivery10.5%Actual Past Growth
Expectation Gap-15.3%Growth Jump Needed
Expectation Risk3/100Price Risk Score
CONSERVATIVE (-7%)BALANCEDDEMANDING (22%)
Historical (10.5%)
Market (-4.8%)
Valuation Summary

Using the Discounted Cash Flow (DCF) model, the market is pricing EXPLEOSOL for -4.8% long-term growth versus 10.5% historical delivery. Current expectations appear achievable, and historical fundamentals provide strong support.

Business Delivery Capacity

Performance quality vs historical benchmarks
Historical Delivery Assessment
Revenue Growth SupportObserved CAGR vs cost of capital baseline
10.5% CAGR
✓ Achieved
Operating Profitability SupportEBIT margins compared to historical standards
13.7% Margin
✗ Weak Margin
Cash Flow Generation SupportOperating cash flow conversion and support cushion
78.0% Conv
✓ Positive
Capital Leverage RiskLeverage indicators and solvency pressure
Clean
✓ Clean
Delivery Capacity Index
75/100
HIGH CAPACITY

Historical business performance currently provides robust support for the market's implied growth assumptions. Improvement in revenue growth and operating efficiency would strengthen expectation support.

WHY IS EXPECTATION RISK ELEVATED?

Risk Drivers:
✓Weak profitability support

Valuation Context

Historical Valuation59th percentile
Cash Yield Support9.71% (Strong)
Sector Premium-65% EV/EBITDA
Current Valuation RegimeConservative

WHAT MUST HAPPEN FOR CURRENT PRICE TO BE CORRECT?

MARKET REQUIRED METRICS
Assumption MetricRequired (To justify current price)Historical Delivery (Average)Fulfillment Assessment
Revenue Growth (CAGR)-4.8%10.5%Achievable
Operating Margin (EBIT)15.8%13.7%Demanding
Free Cash Flow Conversion62.0%78.0%Achievable

*Required metrics indicate the operating efficiency and revenue expansion parameters that must be sustained long-term to justify the current stock price.

Advanced Valuation Analytics
Sentinel Expectation Assessment

The current valuation assumes business performance below the company's historical record. Historical operating performance currently provides partial evidence that these expectations are sustainable. Continued stronger profitability would be required to justify current pricing.

Market Structure Methodology

Flagium separates Business Risk from Market Structure. Business analysis explains what is happening inside the company. Market Structure measures how investors are behaving through price trends, momentum, participation, and institutional activity. Divergences between the two often reveal important transitions before they become obvious.

Market Structure
STAGE 3
TOPPING OUTPROFIT TAKING
Stage Progress
Measures the progress of the stock's current price, volume, and momentum characteristic alignments.
20%
TrendDistribution
MomentumNeutral
ParticipationNeutral
A/D FlowDeteriorating
Sentinel Market Insight

The stock remains in a confirmed Stage 3 distribution phase. Institutional participation has also deteriorated, compounding the weakening trend as momentum is beginning to decay. Current price action does not yet confirm a decisive breakdown or a renewed advance.

What Is Driving Market Structure?

Market Drivers
✗Long-term trend remains below the 150DMA
✗Long-term trend remains below the 200DMA
✗RS continues to lag the market
✗A/D flow has deteriorated
✗Momentum remains negative
Summary
🟡Partial Confirmation

Market structure shows partial alignment with the underlying fundamental risk profile.

Market Cycle Stage Analysis

Stan Weinstein 4-Stage Cycle
S1
Base Building(Institutional accumulation & base building)
S2
Strong Uptrend(Institutional mark-up & trend continuation)
S3
Topping Out(Institutional distribution & profit taking)
S4
Downtrend(Elevated capital erosion risk)
Stage Lifecycle
Stage Progress
20%
Readiness LabelLow (Early Base Consolidation)
Regime Sessions4 Sessions
Transition Probability5% Low
Measures the alignment and consistency of the stock's price trend relative to its historical volume volatility.
0.2224σ Weak
Trend & Strength
Trend QualitySoftening
150 DMA Slope+1.4388%
Participation & Volume
Total rupee value of shares actually delivered into buyers' Demat accounts today (excluding intraday trades). Delivery % indicates what portion of today's total trade was held as delivery rather than squared off intraday.
₹0.6 Cr68.17% Delivery (High Conviction)
Compares the 21-day average delivery turnover against the 200-day long-term baseline. Delivery expansion above baseline confirms a structural accumulation trend.
▼ 45.5% (21D vs 200D Avg)Delivery Volume Drying Up
Avg Turnover (200D)
The 200-day average daily traded turnover in ₹ Crore. Represents baseline trading depth and capacity to enter or exit positions with minimal slippage.
₹7.5 Cr
Liquidity Tier
Categorizes trading liquidity depth based on 200-day average turnover: Liquid (≥₹100 Cr/day), Low Liquidity (₹50–₹100 Cr/day), or Illiquid (<₹50 Cr/day) for sizing and slippage risk control.
Illiquid (High Slippage Risk)
Participation
Evaluates current volume participation against historical baseline turnover. Healthy (≥1.2x) confirms active broad-market sponsorship, while Weak (<0.8x) indicates lack of volume conviction.
Weak

Momentum & A/D Flow

Price Momentum
Momentum StrengthWeakening momentum trend
Price momentum score in standard deviations (σ). Readings beyond ±2.0σ indicate extreme momentum shifts.
-0.6012σ
Universe Rank
#1952 of 2275Bottom 14.20% in momentum strength
A/D Flow Accumulation
21D Flow Score
21-day cumulative volume-weighted A/D flow score in standard deviations (σ).
-0.11σ
7D Flow TrendDeteriorating
EXPLEOSOL
STAGE 3 • TOPPING
—
C:—
Loading Market Structure Data...

Methodology & Regulatory Disclaimer

Flagium AI is an automated financial data analytics and research platform providing quantitative risk, forensic, and valuation analytics for informational and educational purposes only. Flagium AI is not registered with SEBI as a Research Analyst or Investment Adviser under SEBI regulations. These analytics do not constitute financial planning, investment advice, or recommendations to buy, sell, or hold any security.

Investments in securities market are subject to market risks. Read all the related documents carefully before investing. Please consult a SEBI-registered Investment Adviser before acting on any data presented.

📬 Flagium Risk Brief — Track forensic risks on EXPLEOSOL & 3 market anomalies weekly

See a sample issue →